Therapy of malignant hamster insulinomas with monoamine precursors.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use*; D007516:Adenoma, Islet Cell / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D006224:Cricetinae; D004298:Dopamine / Q000378:metabolism; D015103:Droxidopa / Q000627:therapeutic use*; D007980:Levodopa / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D010293:Pargyline / Q000627:therapeutic use; D012694:Serine / Q000031:analogs & derivatives*; D012701:Serotonin / Q000378:metabolism
D012701:Serotonin; D012694:Serine; D007980:Levodopa; D010293:Pargyline; D006916:5-Hydroxytryptophan; D015103:Droxidopa; D004298:Dopamine; D009638:Norepinephrine